Subscribe to Email Alerts
Menu
About Us
About INOVIQ
Market Opportunity
Board
The Team
Advisors
Partners
Distributors
Compliance
Careers
Technology
Our Science
NETs Biomarker Capture Platform
SubB2M Pan-Cancer Probe
BARD1 Biomarker Technology
hTERT ICC Assay
Intellectual Property
Publications
Business Development
Products
Our Products
EXO-NET® Pan-Exosome
Product Overview
Data & Figures
Ordering
Resources
hTERT ICC Test
Pipeline
Development Pipeline
Investors
Investor Overview
ASX Announcements
Annual & Financial Reports
Presentations
Share Price Information
AGM
INOVIQ Fact Sheet
Corporate Governance
Shareholder Services
FAQ
Analyst Reports
Conferences & Events
Media
INOVIQ in the News
Contact
Contact Us
Subscribe to Email Alerts
INOVIQ in the News
Heading &
Sub-heading can be edited through HQI
Media
>
INOVIQ in the News
INOVIQ in the News
INOVIQ in the News
Filter by Year:
2023
2022
2021
2020
2018
2017
29-Jul-2022
INOVIQ (ASX:IIQ) discusses US milestones
26-Jul-2022
INOVIQ study validates the use of SubB2M as an aid in diagnosing malignant melanoma
26-Jul-2022
Energy, miners and BNPL shares lead the way: Aus shares close 0.3% higher
26-Jul-2022
ASX in a holding pattern: Aus shares 0.2% higher at noon
22-Jul-2022
INOVIQ expands US footprint with new sales team
1-Jul-2022
Energy and miners drag ASX lower, down 0.6% over the week
1-Jul-2022
INOVIQ (ASX:IIQ) granted SubB2M US patent for diagnostic applications
22-Apr-2022
Inoviq expands collaboration with UQ to develop exosome-based ovarian cancer screening test
5-Apr-2022
INOVIQ wants to beat cancer to the punch with world-first diagnostic solutions
Previous
1
2
